Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘FDA’

February 22, 2021

Mayo Clinic Research in the news — 2/22/2021

By Elizabeth Zimmermann Elizabeth Zimmermann

Over the last week, Mayo Clinic researchers and expertise have been cited in wide range of news stories, from the ever present COVID-19 to telehealth, participation in cancer clinical trials, creatine supplements, artificial intelligence and more. Read on for headlines, excerpts and links. ‘Knowledge is Power’: Advocating for More Representation in Cancer-Related Clinical Trials Cure, […]

View full entry

Tags: Andrew Jagim, artificial intelligence, Bernard Gersh, blood pressure, Brian Pickering, cancer, CAR T-cell therapy, cardiology, cardiovascular medicine, clinical trials, COVID-19, FDA


January 29, 2021

IMPACT Bootcamp: Navigating the Journey from Digital Health Technologies to Meaningful Patient Outcomes

By Advancing the Science contributor Advancing the Science contributor

Are you a digital health innovator? Are you building sensors, wearables, or other digital health tools to be used in clinical trials to capture information about how patients feel, function, or survive? Join the U.S. Food and Drug Administration, the Yale University and Mayo Clinic CERSI and the Yale School of Medicine Center for Outcomes Research and Evaluation […]

View full entry

Tags: artificial intelligence, Center for the Science of Health Care Delivery, clinical trials, digital health, FDA, health technology, medical innovation, patient reported outcomes, research, research education, Yale


January 5, 2021

Looking back on 2020: A successful year of research at Mayo Clinic in Florida

By Advancing the Science contributor Advancing the Science contributor

At Mayo Clinic, Research and Education provide the basis for all we are able to do for patients today. Furthermore, they enable practice transformation as we seek to meet future patient needs. From new capabilities in cell therapy and immunotherapy, to advances in neurodegenerative diseases and studies of the virus that causes COVID-19, research at Mayo Clinic continued […]

View full entry

Tags: Alzheimer's disease, Ben Pollock, biomanufacturing, biomarkers, biostatistics, brain, cancer, CAR-T, carbon ion therapy, Center for Regenerative Medicine, chemotherapy, clinical research


April 6, 2020

Mayo Clinic Research in the News — Week in Review 4/6/2020

By Elizabeth Zimmermann Elizabeth Zimmermann

In the last week, as you might imagine, most of the news being covered by the media is about COVID-19. We’ve included an excerpt and link to several of these stories discussing Mayo Clinic Research. We found a couple items covering other things we are working on, so included them first, for your awareness. Study: […]

View full entry

Tags: blood test, cancer, cancer screening, cardiology, clinical trials, COVID-19, FDA, Gregory Poland, Henry Ting, immune system, Mayo Clinic Laboratories, Michael Ackerman


April 1, 2020

Research News Roundup–March 2020

By Elizabeth Zimmermann Elizabeth Zimmermann

Even though it’s April Fool’s Day, the stories we share in this monthly column are no joke. Because since last month our world has shifted focus, we’ve divided these releases into two sections – COVID-related, and everything else. “Everything else” is at the end this month, because it is the bigger section, with nearly a […]

View full entry

Tags: AFib, Alzheimer's disease, anesthesiology, cardiology, cardiovascular medicine, clinical trials, COVID-19, Department of Laboratory Medicine and Pathology, FDA, Fredric Meyer, heart attack, heart disease


August 19, 2019

Yale and Mayo Clinic awarded FDA grant to study opioid prescribing and use

By Advancing the Science contributor Advancing the Science contributor

— Yale University Office of Public Affairs & Communications Yale University and Mayo Clinic have been awarded a grant for up to $5.3 million over two years by the U.S. Food and Drug Administration (FDA) to study patients’ experiences with pain and use of opioids prescribed for acute pain. This project is part of the Center of Excellence in Regulatory Science and Innovation (CERSI), […]

View full entry

Tags: Center for the Science of Health Care Delivery, FDA, Nilay Shah, opioids


May 3, 2016

OLD DRUG OR NEW?

By Elizabeth Zimmermann Elizabeth Zimmermann

Determining which drug works better for which patients “Our findings definitely point toward important age-related risk that merits consideration when doctors are making treatment recommendations,” says lead author Neena Abraham, M.D. To the average TV viewer, it may seem like new drugs flood the marketplace daily. However, from the 1950s until just recently, warfarin was […]

View full entry

Tags: anticoagulant, atrial fibrillation, cardiology, Center for the Science of Health Care Delivery, FDA, Neena Abraham


Contact Us · Privacy Policy